Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Ruud Dings

Concepts (317)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Angiogenesis Inhibitors
25
2022
183
3.830
Why?
Proteins
17
2010
353
2.290
Why?
Neovascularization, Pathologic
17
2022
158
2.270
Why?
Calixarenes
7
2017
9
1.830
Why?
Melanoma, Experimental
6
2021
34
1.740
Why?
Galectin 1
8
2024
19
1.720
Why?
Antineoplastic Agents
14
2024
1216
1.470
Why?
Peptides
20
2017
239
1.270
Why?
Mice
47
2024
5899
1.210
Why?
Neoplasms
14
2024
1314
1.130
Why?
Animals
53
2024
13485
0.990
Why?
Endothelial Cells
10
2022
283
0.970
Why?
Lung Neoplasms
5
2024
643
0.960
Why?
Gold
7
2023
81
0.850
Why?
Ovarian Neoplasms
8
2008
455
0.830
Why?
Oxygen
6
2020
332
0.800
Why?
Cell Line, Tumor
18
2024
1429
0.760
Why?
Carcinoma, Non-Small-Cell Lung
1
2024
177
0.720
Why?
Carcinoma, Squamous Cell
4
2019
331
0.710
Why?
Proto-Oncogene Proteins c-met
1
2021
23
0.680
Why?
Peptide Fragments
5
2013
214
0.680
Why?
Mammary Neoplasms, Experimental
6
2015
122
0.670
Why?
Radiation-Sensitizing Agents
4
2023
50
0.660
Why?
Head and Neck Neoplasms
3
2019
289
0.650
Why?
Carcinoma, Lewis Lung
1
2019
10
0.630
Why?
Molecular Targeted Therapy
2
2018
135
0.610
Why?
Preservation, Biological
1
2018
9
0.600
Why?
Lymphocytes, Tumor-Infiltrating
1
2019
86
0.600
Why?
Radiation Tolerance
5
2020
78
0.590
Why?
Protein Kinase Inhibitors
1
2021
231
0.590
Why?
CD8-Positive T-Lymphocytes
1
2019
140
0.580
Why?
Anti-Bacterial Agents
4
2019
816
0.580
Why?
Galectins
1
2018
7
0.570
Why?
Metal Nanoparticles
4
2023
66
0.540
Why?
Hyperthermia, Induced
3
2019
114
0.530
Why?
Bacteria
1
2018
223
0.520
Why?
Mice, Nude
12
2019
230
0.520
Why?
Radiotherapy
5
2021
128
0.500
Why?
Xenograft Model Antitumor Assays
11
2020
218
0.480
Why?
Pseudomonas aeruginosa
2
2013
79
0.450
Why?
Combined Modality Therapy
11
2020
641
0.410
Why?
Benzofurans
2
2012
19
0.400
Why?
Cytotoxins
1
2013
15
0.400
Why?
Cell Proliferation
10
2024
1013
0.390
Why?
Drug Design
4
2014
122
0.390
Why?
Oxidation-Reduction
3
2024
327
0.390
Why?
Pseudomonas Infections
1
2013
55
0.390
Why?
Endothelium, Vascular
8
2010
263
0.380
Why?
Humans
44
2024
52441
0.380
Why?
Carbohydrate Metabolism
1
2012
25
0.380
Why?
Nanostructures
3
2023
41
0.370
Why?
Neoplasms, Experimental
4
2020
111
0.370
Why?
Benzeneacetamides
2
2024
12
0.370
Why?
Glutaminase
2
2024
18
0.370
Why?
Bacteremia
1
2013
87
0.370
Why?
Sesquiterpenes
3
2010
89
0.350
Why?
Angiostatic Proteins
1
2011
1
0.350
Why?
Immunity, Cellular
1
2011
64
0.340
Why?
Cell Survival
8
2024
598
0.330
Why?
Molecular Mimicry
2
2007
35
0.330
Why?
Dendritic Cells
3
2021
132
0.330
Why?
Endothelium
4
2022
38
0.320
Why?
Carboplatin
3
2024
55
0.310
Why?
Antineoplastic Combined Chemotherapy Protocols
2
2008
1020
0.310
Why?
Tumor Necrosis Factor-alpha
4
2019
390
0.310
Why?
Immunotherapy, Adoptive
1
2011
156
0.300
Why?
Apoptosis
7
2024
1120
0.300
Why?
Cells, Cultured
8
2013
1583
0.300
Why?
Vascular Endothelial Growth Factor A
7
2022
186
0.300
Why?
Intercellular Adhesion Molecule-1
5
2022
59
0.290
Why?
T-Lymphocytes
1
2011
318
0.290
Why?
Structure-Activity Relationship
6
2012
399
0.290
Why?
Polyethylene Glycols
3
2021
93
0.290
Why?
Mice, Inbred C57BL
8
2021
1888
0.280
Why?
Phototherapy
2
2019
26
0.280
Why?
Amino Acid Sequence
5
2012
576
0.270
Why?
Tumor Cells, Cultured
6
2019
441
0.270
Why?
Female
24
2020
28277
0.260
Why?
Drug Resistance, Neoplasm
2
2024
336
0.260
Why?
Magnetic Resonance Spectroscopy
5
2012
249
0.250
Why?
Antibodies, Monoclonal
2
2007
475
0.250
Why?
Blood Vessels
4
2015
73
0.250
Why?
Disease Models, Animal
7
2020
1483
0.240
Why?
Molecular Sequence Data
5
2012
778
0.240
Why?
Nanoparticles
2
2017
131
0.230
Why?
Cell Division
7
2010
288
0.220
Why?
Bystander Effect
1
2024
24
0.220
Why?
Cysteine
1
2024
51
0.220
Why?
Human Umbilical Vein Endothelial Cells
3
2014
102
0.210
Why?
Buthionine Sulfoximine
1
2024
13
0.210
Why?
Nanotubes
2
2021
17
0.210
Why?
Models, Molecular
4
2024
356
0.210
Why?
Thiadiazoles
2
2024
18
0.200
Why?
Flow Cytometry
2
2017
396
0.200
Why?
Cisplatin
1
2024
282
0.180
Why?
Alanine
3
2012
43
0.180
Why?
Protein Binding
3
2012
673
0.180
Why?
Carcinoma, Renal Cell
1
2022
112
0.180
Why?
Binding Sites
2
2012
379
0.180
Why?
Optical Imaging
2
2020
25
0.170
Why?
Silver
2
2021
48
0.170
Why?
Polyurethanes
1
2021
9
0.170
Why?
Kidney Neoplasms
1
2022
181
0.170
Why?
Radiation
1
2020
14
0.170
Why?
Materials Testing
1
2021
55
0.170
Why?
Forkhead Transcription Factors
1
2021
120
0.170
Why?
Spectrum Analysis
1
2020
50
0.170
Why?
Biocompatible Materials
1
2021
67
0.160
Why?
Mice, Inbred BALB C
5
2020
304
0.160
Why?
CD4-Positive T-Lymphocytes
1
2021
165
0.160
Why?
Mice, Knockout
3
2012
903
0.160
Why?
Neoplasm Transplantation
5
2007
86
0.160
Why?
Disease Progression
3
2019
870
0.160
Why?
Oxygen Consumption
1
2020
193
0.160
Why?
Lactose
2
2024
8
0.150
Why?
Spectrum Analysis, Raman
1
2019
42
0.150
Why?
Immunotherapy
1
2020
251
0.150
Why?
Specimen Handling
1
2018
59
0.140
Why?
Biological Assay
1
2018
38
0.140
Why?
Time Factors
6
2017
2987
0.140
Why?
Drug Delivery Systems
2
2019
148
0.140
Why?
Indazoles
1
2018
47
0.140
Why?
Hypoxia-Inducible Factor 1, alpha Subunit
1
2018
60
0.140
Why?
Carbohydrates
1
2018
41
0.140
Why?
Temperature
1
2018
166
0.140
Why?
Feces
1
2018
159
0.140
Why?
Cell Hypoxia
4
2015
82
0.140
Why?
Histocompatibility Antigens Class II
1
2017
35
0.130
Why?
Neoplastic Cells, Circulating
1
2017
34
0.130
Why?
Tumor Microenvironment
1
2019
257
0.130
Why?
Male
9
2019
26874
0.130
Why?
Drug Therapy, Combination
1
2018
404
0.130
Why?
Epithelial Cells
1
2018
217
0.130
Why?
Cell Line
4
2017
1020
0.130
Why?
Lipopolysaccharides
2
2008
205
0.120
Why?
Umbilical Veins
4
2010
21
0.120
Why?
Enzyme Inhibitors
1
2018
378
0.120
Why?
Molecular Imaging
1
2015
28
0.120
Why?
Leukocytes
3
2006
54
0.120
Why?
Azides
1
2014
9
0.110
Why?
Tumor Burden
2
2013
132
0.110
Why?
Fluorine Radioisotopes
1
2014
25
0.110
Why?
Immunohistochemistry
5
2020
977
0.110
Why?
Cell Transformation, Neoplastic
2
2007
187
0.110
Why?
Interleukin-2
2
2021
69
0.110
Why?
Drug Synergism
2
2005
147
0.100
Why?
Cell Adhesion
3
2006
162
0.100
Why?
Piperacillin
1
2013
24
0.100
Why?
Peptidomimetics
1
2012
2
0.100
Why?
Penicillanic Acid
1
2013
21
0.100
Why?
Agglutination Tests
1
2012
5
0.100
Why?
Allosteric Regulation
1
2012
17
0.100
Why?
Inflammation Mediators
1
2013
113
0.090
Why?
Cell Cycle
1
2013
236
0.090
Why?
Antimicrobial Cationic Peptides
2
2008
27
0.090
Why?
Neoplastic Stem Cells
1
2012
88
0.090
Why?
Up-Regulation
2
2011
462
0.090
Why?
Partial Pressure
1
2011
14
0.090
Why?
Glutamine
2
2024
177
0.080
Why?
Metformin
1
2012
82
0.080
Why?
Adjuvants, Immunologic
1
2011
51
0.080
Why?
Fibroblasts
1
2013
357
0.080
Why?
Chemotherapy, Adjuvant
1
2011
122
0.080
Why?
Cell Movement
4
2006
271
0.080
Why?
Spiro Compounds
1
2010
8
0.080
Why?
Cytokines
1
2013
622
0.080
Why?
Lignans
1
2008
7
0.070
Why?
Salmonella typhimurium
1
2008
40
0.070
Why?
Klebsiella pneumoniae
1
2008
21
0.070
Why?
Amino Acid Substitution
1
2008
79
0.070
Why?
Furans
1
2008
31
0.070
Why?
Surface Properties
1
2007
61
0.070
Why?
Escherichia coli
1
2008
182
0.070
Why?
Angiostatins
2
2006
2
0.070
Why?
Endotoxins
1
2006
23
0.070
Why?
Vascular Neoplasms
1
2007
17
0.060
Why?
Concept Formation
1
2006
13
0.060
Why?
Gram-Negative Bacteria
1
2006
34
0.060
Why?
Protein Structure, Secondary
2
2003
73
0.060
Why?
Interleukin-8
1
2006
86
0.060
Why?
Genes, Synthetic
1
2005
1
0.060
Why?
Protein Engineering
1
2005
18
0.060
Why?
Antibodies, Monoclonal, Humanized
1
2007
230
0.060
Why?
Cloning, Molecular
1
2005
181
0.060
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2006
148
0.060
Why?
Angiogenic Proteins
1
2004
5
0.060
Why?
Colonic Neoplasms
1
2006
163
0.060
Why?
Histones
1
2006
315
0.060
Why?
Dietary Supplements
1
2008
470
0.060
Why?
Protein Unfolding
1
2024
7
0.050
Why?
Feasibility Studies
1
2006
404
0.050
Why?
Disulfides
1
2024
17
0.050
Why?
Diphtheria Toxin
1
2004
4
0.050
Why?
Mutagenesis, Site-Directed
1
2024
100
0.050
Why?
Protein Folding
1
2024
60
0.050
Why?
Mammary Neoplasms, Animal
1
2004
33
0.050
Why?
Osmosis
1
2003
4
0.050
Why?
Infusion Pumps
1
2003
12
0.050
Why?
Dose-Response Relationship, Drug
2
2004
1365
0.050
Why?
Circular Dichroism
1
2003
42
0.050
Why?
Plasminogen
1
2003
2
0.050
Why?
Serum Albumin
1
2003
57
0.050
Why?
Extracellular Matrix
1
2003
116
0.050
Why?
Immune Tolerance
1
2022
91
0.050
Why?
Gene Expression Regulation, Neoplastic
4
2008
853
0.050
Why?
Reactive Oxygen Species
1
2024
415
0.050
Why?
Endostatins
3
2007
4
0.050
Why?
Neoplasm Invasiveness
1
2022
278
0.050
Why?
Melanoma
1
2004
272
0.040
Why?
Immune System
1
2021
42
0.040
Why?
Immunity
1
2021
35
0.040
Why?
Ethers
1
2021
7
0.040
Why?
Regenerative Medicine
1
2021
12
0.040
Why?
Tissue Scaffolds
1
2021
40
0.040
Why?
Angiogenesis Inducing Agents
1
2000
7
0.040
Why?
Dose-Response Relationship, Radiation
1
2020
185
0.040
Why?
Adenocarcinoma
1
2004
403
0.040
Why?
Tissue Engineering
1
2021
74
0.040
Why?
Bone Marrow Cells
1
2021
188
0.040
Why?
Mice, Inbred C3H
2
2012
80
0.040
Why?
Gene Expression Profiling
1
2004
1099
0.040
Why?
Skin Neoplasms
1
2004
496
0.040
Why?
Flavin-Adenine Dinucleotide
1
2018
4
0.040
Why?
NAD
1
2018
46
0.040
Why?
Inflammation
1
2022
649
0.040
Why?
Microcirculation
2
2010
64
0.040
Why?
Guidelines as Topic
1
2018
111
0.030
Why?
Microscopy, Fluorescence
1
2018
140
0.030
Why?
Glutathione
1
2019
301
0.030
Why?
Phagocytosis
1
2017
54
0.030
Why?
Glycolysis
1
2017
70
0.030
Why?
Transplantation, Heterologous
2
2008
78
0.030
Why?
Clonal Anergy
2
2006
13
0.030
Why?
Extracellular Fluid
1
2015
14
0.030
Why?
Nitroimidazoles
1
2015
16
0.030
Why?
Microbubbles
1
2015
27
0.030
Why?
Cell Count
1
2015
143
0.030
Why?
Stromal Cells
1
2015
76
0.030
Why?
Pressure
1
2015
100
0.030
Why?
Down-Regulation
2
2006
348
0.030
Why?
Drug Evaluation, Preclinical
1
2015
141
0.030
Why?
Paclitaxel
2
2006
91
0.030
Why?
Cycloaddition Reaction
1
2014
1
0.030
Why?
Radiochemistry
1
2014
2
0.030
Why?
Click Chemistry
1
2014
3
0.030
Why?
Random Allocation
1
2015
286
0.030
Why?
Recombinant Proteins
2
2006
490
0.030
Why?
Imaging, Three-Dimensional
1
2015
150
0.030
Why?
Radiotherapy Dosage
1
2015
256
0.030
Why?
Cell Differentiation
1
2017
667
0.030
Why?
Contrast Media
1
2015
173
0.030
Why?
Molecular Structure
1
2014
317
0.030
Why?
Ultrasonography
1
2015
416
0.030
Why?
Chromatography, High Pressure Liquid
1
2014
333
0.030
Why?
Ribosomal Protein S6 Kinases
1
2012
8
0.020
Why?
Adenylate Kinase
1
2012
10
0.020
Why?
TOR Serine-Threonine Kinases
1
2012
83
0.020
Why?
Rats
2
2008
3228
0.020
Why?
Radiometry
1
2012
125
0.020
Why?
4-Butyrolactone
1
2008
5
0.020
Why?
Butylene Glycols
1
2008
14
0.020
Why?
Phytoestrogens
1
2008
23
0.020
Why?
9,10-Dimethyl-1,2-benzanthracene
1
2008
50
0.020
Why?
Ovariectomy
1
2008
115
0.020
Why?
Receptors, Progesterone
1
2008
68
0.020
Why?
Estrogen Receptor beta
1
2008
54
0.020
Why?
Estrogen Receptor alpha
1
2008
86
0.020
Why?
Carcinogens
1
2008
194
0.020
Why?
Cell Growth Processes
1
2007
24
0.020
Why?
Horseshoe Crabs
1
2006
3
0.020
Why?
Blood Bactericidal Activity
1
2006
4
0.020
Why?
Lipid A
1
2006
4
0.020
Why?
Polymyxin B
1
2006
4
0.020
Why?
Neutralization Tests
1
2006
28
0.020
Why?
Cytidine
1
2006
5
0.020
Why?
Pyrroles
1
2007
73
0.020
Why?
DNA Modification Methylases
1
2006
28
0.020
Why?
Endotoxemia
1
2006
35
0.020
Why?
Acetylation
1
2006
96
0.020
Why?
Methylation
1
2006
124
0.020
Why?
Vimentin
1
2006
31
0.020
Why?
Chick Embryo
1
2006
79
0.020
Why?
Blood Proteins
1
2006
84
0.020
Why?
Gene Silencing
1
2006
122
0.020
Why?
Transfection
1
2007
365
0.020
Why?
Nucleic Acid Hybridization
1
2006
54
0.020
Why?
Cyclohexanes
1
2006
4
0.020
Why?
Histone Deacetylase Inhibitors
1
2006
57
0.020
Why?
Zebrafish
1
2006
61
0.020
Why?
Histone Deacetylases
1
2006
50
0.020
Why?
Vascular Cell Adhesion Molecule-1
1
2006
38
0.020
Why?
Pichia
1
2005
8
0.010
Why?
Gene Transfer Techniques
1
2005
44
0.010
Why?
Cyclophosphamide
1
2006
176
0.010
Why?
Neovascularization, Physiologic
1
2005
86
0.010
Why?
Sequence Homology, Nucleic Acid
1
2004
48
0.010
Why?
Membrane Proteins
1
2006
344
0.010
Why?
Indoles
1
2007
283
0.010
Why?
Treatment Outcome
1
2014
5508
0.010
Why?
Necrosis
1
2004
169
0.010
Why?
Antibodies
1
2004
144
0.010
Why?
Skin
1
2007
416
0.010
Why?
In Situ Nick-End Labeling
1
2003
54
0.010
Why?
Base Sequence
1
2004
632
0.010
Why?
Sequence Homology, Amino Acid
1
2003
140
0.010
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2004
580
0.010
Why?
Epigenesis, Genetic
1
2006
396
0.010
Why?
Mice, Transgenic
1
2004
566
0.010
Why?
RNA, Messenger
1
2004
1134
0.010
Why?
Endothelial Growth Factors
1
2000
11
0.010
Why?
Vascular Endothelial Growth Factors
1
2000
15
0.010
Why?
Fibroblast Growth Factor 2
1
2000
35
0.010
Why?
Lymphokines
1
2000
20
0.010
Why?
Scrotum
1
2000
31
0.010
Why?
Interleukin-1
1
2000
102
0.010
Why?
Models, Biological
1
2002
735
0.010
Why?
Breast Neoplasms
1
2004
1203
0.010
Why?
Dings's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description